CN219846589U - Wearable emotion monitoring and early warning system - Google Patents
Wearable emotion monitoring and early warning system Download PDFInfo
- Publication number
- CN219846589U CN219846589U CN202222329369.XU CN202222329369U CN219846589U CN 219846589 U CN219846589 U CN 219846589U CN 202222329369 U CN202222329369 U CN 202222329369U CN 219846589 U CN219846589 U CN 219846589U
- Authority
- CN
- China
- Prior art keywords
- early warning
- cortisol
- concentration
- serotonin
- dopamine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000008451 emotion Effects 0.000 title claims abstract description 30
- 238000012544 monitoring process Methods 0.000 title claims abstract description 22
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 claims abstract description 96
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 claims abstract description 88
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 claims abstract description 88
- 238000001514 detection method Methods 0.000 claims abstract description 55
- 229960000890 hydrocortisone Drugs 0.000 claims abstract description 48
- 229960003638 dopamine Drugs 0.000 claims abstract description 44
- 229940076279 serotonin Drugs 0.000 claims abstract description 44
- 230000002159 abnormal effect Effects 0.000 claims abstract description 12
- 230000028327 secretion Effects 0.000 claims abstract description 6
- 238000000034 method Methods 0.000 claims abstract description 5
- 230000008569 process Effects 0.000 claims abstract description 3
- 108091023037 Aptamer Proteins 0.000 claims description 34
- 230000005669 field effect Effects 0.000 claims description 25
- 239000000758 substrate Substances 0.000 claims description 15
- 108091008102 DNA aptamers Proteins 0.000 claims description 5
- 238000004146 energy storage Methods 0.000 claims description 5
- 230000008685 targeting Effects 0.000 claims description 4
- 238000002955 isolation Methods 0.000 claims description 3
- 230000002265 prevention Effects 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 201000010099 disease Diseases 0.000 abstract description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 2
- 238000013399 early diagnosis Methods 0.000 abstract 1
- 230000002996 emotional effect Effects 0.000 abstract 1
- 230000008859 change Effects 0.000 description 6
- PJXISJQVUVHSOJ-UHFFFAOYSA-N indium(iii) oxide Chemical compound [O-2].[O-2].[O-2].[In+3].[In+3] PJXISJQVUVHSOJ-UHFFFAOYSA-N 0.000 description 6
- 239000004642 Polyimide Substances 0.000 description 3
- 229920001721 polyimide Polymers 0.000 description 3
- 239000004065 semiconductor Substances 0.000 description 3
- 238000013461 design Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 230000004630 mental health Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 208000020016 psychiatric disease Diseases 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010012374 Depressed mood Diseases 0.000 description 1
- 206010027951 Mood swings Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 238000009740 moulding (composite fabrication) Methods 0.000 description 1
- 150000004713 phosphodiesters Chemical group 0.000 description 1
- 238000001259 photo etching Methods 0.000 description 1
- 238000001020 plasma etching Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000004528 spin coating Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Abstract
The utility model discloses a wearable emotion monitoring and early warning system, wherein an acquisition module comprises a cortisol detection unit, a dopamine detection unit and a serotonin detection unit, wherein the cortisol detection unit, the dopamine detection unit and the serotonin detection unit are respectively connected with a control module, and the control module respectively analyzes and processes detection signals to obtain detection results of cortisol concentration, dopamine concentration and serotonin concentration and displays the detection results through a display module; the judging module judges the emotion of the wearer according to the detection results of the cortisol concentration, the dopamine concentration and the serotonin concentration, and sends the judgment result to the control module; the early warning module is used for giving early warning to the abnormal judgment result. The utility model comprehensively judges the emotional state by monitoring the concentration of serotonin, dopamine and cortisol in the skin secretion in real time and provides early warning in time, thereby being beneficial to early diagnosis and early prevention of psychological diseases.
Description
Technical Field
The utility model belongs to the technical field of psychological operation devices, and particularly relates to a wearable emotion monitoring and early warning system.
Background
When people bear larger pressure, the phenomena of mood swings are larger, such as mood depression, mood anxiety and the like often occur, if the hidden trouble of psychological diseases is easily caused by the intervention is not found in time, the behavior which is difficult to control is made, and even the safety and the life are endangered. Therefore, the method is necessary for timely detecting and early warning emotion.
In the existing emotion detection, physiological indexes such as heartbeat, pulse and body temperature are detected, and the physiological indexes are affected by a plurality of factors, so that emotion variation is difficult to accurately reflect. Researches show that cortisol, serotonin, dopamine and the like have great relativity with emotion control and expression, and are biological signal molecules for feeding back mental states and mental health states, so that if detection and judgment of related biological signal molecules can be realized, the method has important significance for early warning and prevention of mental diseases.
Disclosure of Invention
Aiming at the defects existing in the prior art, the utility model provides a wearable emotion monitoring and early warning system.
In order to achieve the above object, the technical scheme of the present utility model is as follows:
a wearable emotion monitoring and early warning system comprises an acquisition module, a control module, a display module, a judgment module and an early warning module;
the acquisition module is used for acquiring signals of skin secretion of a wearer and comprises a cortisol detection unit for acquiring an electric signal with characteristics of cortisol concentration, a dopamine detection unit for acquiring an electric signal with characteristics of dopamine concentration and a serotonin detection unit for acquiring an electric signal with characteristics of serotonin concentration;
the cortisol detection unit, the dopamine detection unit and the serotonin detection unit are respectively connected with the control module, and the control module respectively analyzes and processes the cortisol concentration characteristic electrical signal, the dopamine concentration characteristic electrical signal and the serotonin concentration characteristic electrical signal to obtain detection results of cortisol concentration, dopamine concentration and serotonin concentration and displays the detection results through the display module;
the judging module is connected with the control module and is used for judging the emotion of the wearer according to the detection results of the cortisol concentration, the dopamine concentration and the serotonin concentration and sending the judgment results to the control module;
the early warning module is connected with the control module and used for giving early warning to the abnormal judgment result.
Optionally, the cortisol detection unit comprises a cortisol aptamer field effect transistor, the dopamine detection unit comprises a dopamine aptamer field effect transistor, and the serotonin detection unit comprises a serotonin aptamer field effect transistor.
Optionally, the cortisol aptamer field effect transistor, the dopamine aptamer field effect transistor and the serotonin aptamer field effect transistor respectively comprise a substrate and In arranged on the substrate 2 O 3 Layer, provided In 2 O 3 A source electrode and a drain electrode on the layer, and an aptamer layer arranged between the source electrode and the drain electrode, wherein the aptamer layer is respectively provided with DNA aptamers targeting cortisol, dopamine and serotonin; the gate is sensed by skin exudates of the wearer.
Optionally, the cortisol aptamer field effect transistor, the dopamine aptamer field effect transistor and the serotonin aptamer field effect transistor adopt the same substrate and In 2 O 3 A layer of In 2 O 3 The layers are partitioned by device isolation.
Optionally, the substrate is a flexible substrate, and the In 2 O 3 The thickness of the layer is 3-8 nm.
Optionally, the cortisol concentration characteristic electrical signal, the dopamine concentration characteristic electrical signal and the serotonin concentration characteristic electrical signal are current signals or voltage signals.
Optionally, the early warning module is a vibrator, a buzzer or an LED lamp.
Optionally, the early warning module further includes a wireless signal sending unit.
Optionally, the solar energy storage device further comprises a power module, wherein the power module is an energy storage battery or a solar battery.
Optionally, the wearable emotion monitoring and early warning system is a smart bracelet or a smart watch, wherein the acquisition module is attached to contact with the skin of a wearer.
The beneficial effects of the utility model are as follows:
based on intelligent wearing equipment, the concentration of serotonin, dopamine and cortisol in skin secretion is monitored in real time to comprehensively judge the emotion state, early warning is provided timely, the result is timely and accurate, the mental diseases and the mental health state of people can be quantified, and timely feedback and early prevention are provided; the device has high integration level, is convenient to carry and realizes daily noninvasive monitoring.
Drawings
FIG. 1 is a schematic diagram of a modular construction of a wearable emotion monitoring and early warning system of an embodiment;
fig. 2 is a schematic structural diagram of a cortisol detection unit, a dopamine detection unit and a serotonin detection unit according to an embodiment.
Detailed Description
The utility model is further explained below with reference to the drawings and specific embodiments. The drawings of the present utility model are merely schematic to facilitate understanding of the present utility model, and specific proportions thereof may be adjusted according to design requirements.
Referring to fig. 1, a wearable emotion monitoring and early warning system in an embodiment is a smart watch or a smart bracelet, and includes an acquisition module 1, a control module 2, a display module 3, a judgment module 4, an early warning module 5 and a power supply 6. The acquisition module 1 is arranged in contact with the skin and is used for acquiring signals of target detection objects in skin secretion of a wearer, and comprises a cortisol detection unit 1a used for acquiring cortisol concentration characteristic electric signals, a dopamine detection unit 1b used for acquiring dopamine concentration characteristic electric signals and a serotonin detection unit 1c used for acquiring serotonin concentration characteristic electric signals. The cortisol detection unit 1a, the dopamine detection unit 1b and the serotonin detection unit 1c are respectively connected with the control module 2. The control module 2 is a single chip microcomputer, a control chip or other integrated control circuit structures, has a data analysis processing function and a system control capability, and is used for respectively analyzing and processing the cortisol concentration characteristic electrical signal, the dopamine concentration characteristic electrical signal and the serotonin concentration characteristic electrical signal to obtain detection results of cortisol concentration, dopamine concentration and serotonin concentration, and displaying the detection results on the display module 3. The display module 3 may be selected as a touch screen or a liquid crystal display. The judging module 4 is connected with the control module 2 and is used for judging the emotion of the wearer according to the detection results of the cortisol concentration, the dopamine concentration and the serotonin concentration, and sending the judgment result to the control module 2. The early warning module 5 is connected with the control module 2 and is used for giving early warning to the abnormal judgment result. The power supply 6 is used for supplying power to the emotion monitoring and early warning system, and can be an energy storage battery, a solar battery and the like.
Referring to fig. 2, the cortisol detection unit 1a includes a cortisol aptamer field effect transistor, the dopamine detection unit 1b includes a dopamine aptamer field effect transistor, and the serotonin detection unit 1c includes a serotonin aptamer field effect transistor. The three transistors are integrated on the same substrate 11. The substrate 11 is a flexible substrate, such as a polyimide material. The substrate 11 is provided with In 2 O 3 Layer 12, in 2 O 3 The thickness of the layer 12 is 3 to 8nm, for example, about 4 nm. Indium trioxide precursors are first sprayed onto a polyimide (polyimide) substrate using spin coating and then converted to a thin layer of indium trioxide using solution-based sol-gel technology. And constructing a current path on the indium trioxide layer by utilizing photoetching and reactive ion etching, forming areas of three transistors through device isolation, forming a source electrode and a drain electrode by adopting a Ti/Au laminated layer, and adopting an interdigital structure design for source electrode metal and drain electrode metal to increase the sensitivity. Wherein the source and drain of the cortisol aptamer field effect transistor, the dopamine aptamer field effect transistor and the serotonin aptamer field effect transistor are represented by 13 a/14 a,13 b/14 b and 13 c/14 c, respectively. A cortisol aptamer layer 15a comprising targeted cortisol is formed between the source 13a and the drain 14a of the cortisol detection unit 1aIs a DNA aptamer of (2); a dopamine aptamer layer 15b comprising a DNA aptamer targeting dopamine is formed between the source 13b and the drain 14b of the dopamine-detecting unit 1 b; a serotonin aptamer layer 15c comprising a DNA aptamer targeting serotonin is formed between the source 13c and the drain 14c of the serotonin detection unit 1c. The gate is induced by skin secretions in contact with the aptamer layer between the source and the drain.
Taking cortisol aptamer field effect transistors as an example, the dopamine aptamer-derivatized semiconductor surface is capable of converting cortisol binding to a detectable change in surface charge. Binding of cortisol to the aptamer causes conformational changes in the negatively charged phosphodiester backbone on the DNA and rearrangement of the charged ions in the solution to which it is bound, both of which together cause a change in the surface charge of the transistor. The change of the surface charge of the semiconductor further influences the change of the semiconductor current, so that the measurement of the cortisol content without marking and additional reagent can be realized by detecting the current change and analyzing the current change. Wherein the analysis of the data is effected in a conventional manner.
The judging module 4 compares the detection result with a preset normal range value, and judges the emotion state according to the comparison result, for example, when one index is abnormal, the index is listed as first-level abnormal; when the two indexes are abnormal, the two indexes are classified as second-level abnormal; when all three indexes are abnormal, the three indexes are classified as three-level abnormal, the judging result is sent to the control module 2, and the control module 2 sends an instruction to instruct the early warning module 5 to act correspondingly according to the judging result. The early warning module 5 can be a vibrator, a buzzer or an LED lamp, and can realize vibration with different intensities or different sounds or different color expressions according to different abnormal states. In addition, the early warning module 5 may further include a wireless signal transmitting unit such as bluetooth for transmitting the abnormal signal to the remote terminal.
The above embodiment is only used for further illustrating a wearable emotion monitoring and early warning system of the present utility model, but the present utility model is not limited to the embodiment, and any simple modification, equivalent variation and modification of the above embodiment according to the technical substance of the present utility model falls within the scope of the technical solution of the present utility model.
Claims (8)
1. A wearable emotion monitoring and early warning system is characterized in that: the system comprises an acquisition module, a control module, a display module, a judging module and an early warning module;
the acquisition module is used for acquiring signals of skin secretion of a wearer and comprises a cortisol detection unit for acquiring an electric signal with characteristics of cortisol concentration, a dopamine detection unit for acquiring an electric signal with characteristics of dopamine concentration and a serotonin detection unit for acquiring an electric signal with characteristics of serotonin concentration;
the cortisol detection unit, the dopamine detection unit and the serotonin detection unit are respectively connected with the control module, and the control module respectively analyzes and processes the cortisol concentration characteristic electrical signal, the dopamine concentration characteristic electrical signal and the serotonin concentration characteristic electrical signal to obtain detection results of cortisol concentration, dopamine concentration and serotonin concentration and displays the detection results through the display module; wherein the cortisol detection unit comprises a cortisol aptamer field effect transistor, the dopamine detection unit comprises a dopamine aptamer field effect transistor, and the serotonin detection unit comprises a serotonin aptamer field effect transistor; the cortisol aptamer field effect transistor, the dopamine aptamer field effect transistor and the serotonin aptamer field effect transistor respectively comprise a substrate and In arranged on the substrate 2 O 3 Layer, provided In 2 O 3 A source electrode and a drain electrode on the layer, and an aptamer layer arranged between the source electrode and the drain electrode, wherein the aptamer layer is respectively provided with DNA aptamers targeting cortisol, dopamine and serotonin;
the judging module is connected with the control module and is used for judging the emotion of the wearer according to the detection results of the cortisol concentration, the dopamine concentration and the serotonin concentration and sending the judgment results to the control module;
the early warning module is connected with the control module and used for giving early warning to the abnormal judgment result.
2. The wearable emotion monitoring and early warning system of claim 1, wherein:the cortisol aptamer field effect transistor, the dopamine aptamer field effect transistor and the serotonin aptamer field effect transistor adopt the same substrate and In 2 O 3 A layer of In 2 O 3 The layers are partitioned by device isolation.
3. The wearable emotion monitoring and early warning system of claim 2, wherein: the substrate is a flexible substrate, and the In 2 O 3 The thickness of the layer is 3-8 nm.
4. The wearable emotion monitoring and early warning system of claim 1, wherein: the cortisol concentration characteristic electrical signal, the dopamine concentration characteristic electrical signal and the serotonin concentration characteristic electrical signal are current signals or voltage signals.
5. The wearable emotion monitoring and early warning system of claim 1, wherein: the early warning module is a vibrator, a buzzer or an LED lamp.
6. The wearable emotion monitoring and early warning system of claim 1, wherein: the early warning module further comprises a wireless signal sending unit.
7. The wearable emotion monitoring and early warning system of claim 1, wherein: the solar energy storage device further comprises a power supply module, wherein the power supply module is an energy storage battery or a solar battery.
8. The wearable emotion monitoring and early warning system of claim 1, wherein: the wearable emotion monitoring and early warning system is a smart bracelet or a smart watch, wherein the acquisition module is attached to contact with the skin of a wearer.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202222329369.XU CN219846589U (en) | 2022-08-31 | 2022-08-31 | Wearable emotion monitoring and early warning system |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202222329369.XU CN219846589U (en) | 2022-08-31 | 2022-08-31 | Wearable emotion monitoring and early warning system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN219846589U true CN219846589U (en) | 2023-10-20 |
Family
ID=88370646
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202222329369.XU Active CN219846589U (en) | 2022-08-31 | 2022-08-31 | Wearable emotion monitoring and early warning system |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN219846589U (en) |
-
2022
- 2022-08-31 CN CN202222329369.XU patent/CN219846589U/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3119271B1 (en) | Health state monitoring device | |
| CN103445777B (en) | The monitoring method of sleep and fatigue monitoring class watch device and normalization dingus | |
| KR101239340B1 (en) | Portable pulse measuring device | |
| WO2006025055A3 (en) | Device and method for measuring physiological parameters | |
| CN202677083U (en) | Sleep and fatigue monitoring type watch apparatus | |
| CN107361755A (en) | Intelligent watch with dysarteriotony prompting | |
| CN204945634U (en) | A kind of intelligent watch based on health control | |
| WO2020108626A1 (en) | Intelligent wearable assembly with self-powered flexible electrode | |
| CN104799510A (en) | Multifunctional bracelet for hospitalized patient | |
| CN112631112A (en) | Multifunctional health monitoring smart watch and control method thereof | |
| CN219846589U (en) | Wearable emotion monitoring and early warning system | |
| CN206063138U (en) | The healthy critical warning cloud monitoring system of naturalness night burst | |
| CN204158814U (en) | Electronic infusion autoalarm | |
| CN105741504B (en) | A kind of separate type electronic enclosure system and control method with behavioural analysis ability | |
| CN104274883B (en) | Electronic infusion autoalarm | |
| EP4312797A1 (en) | Fertility prediction from wearable-based physiological data | |
| Rajan et al. | Ambulatory autonomic activity monitoring among at-risk adolescent mothers | |
| CN201002522Y (en) | Sleepiness canceller | |
| CN113080899A (en) | Intelligent vital sign monitoring mattress and monitoring system | |
| CN203263372U (en) | Pulse monitoring equipment and system | |
| Chen et al. | Novel Doppler approach to monitoring driver drowsiness | |
| KR102454346B1 (en) | Method of analyzing biometrics and biometrics analyzing system | |
| CN204654925U (en) | Wearable intelligent device | |
| CN204133465U (en) | Speech auxiliary device | |
| Guo et al. | Design of the intelligent energy‐saving cardiotachometer based on Mbed |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant |